D. Carbone

发表

Focusing in on P53 in hepatocellular carcinoma

D. Carbone, D. Carbone, 1991, Hepatology.

The MspI polymorphism in intron 6 of p53 (TP53) detected by digestion of PCR products.

T. McDaniel, P. Chumakov, E. Chang, 1991, Nucleic acids research.

Analysis of the metabolic switch induced by the spirulina peptide SP6 in high fat diet ApoE-/- mice model: A direct infusion FT-ICR-MS based approach.

P. Campiglia, D. Carbone, E. Sommella, 2020, Journal of pharmaceutical and biomedical analysis.

New Imidazo[2,1-b][1,3,4]Thiadiazole Derivatives Inhibit FAK Phosphorylation and Potentiate the Antiproliferative Effects of Gemcitabine Through Modulation of the Human Equilibrative Nucleoside Transporter-1 in Peritoneal Mesothelioma

E. Giovannetti, G. Peters, N. Zaffaroni, 2020, AntiCancer Research.

A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer Cells

E. Giovannetti, A. Avan, G. Peters, 2021, Molecules.

Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC)

E. Giovannetti, A. Avan, G. Peters, 2021, Cancers.

Recombinant erythropoietin differently affects proliferation of mesothelioma cells but not sensitivity to cisplatin and pemetrexed

D. Carbone, C. Palumbo, R. Bei, 2008, Cancer Chemotherapy and Pharmacology.

3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pancreatic Ductal Adenocarcinoma

E. Giovannetti, N. Funel, G. Peters, 2020, Molecules.

Biological Evaluation of the Antiproliferative and Anti-migratory Activity of a Series of 3-(6-Phenylimidazo[2,1-b][1,3,4]thiadiazol-2-yl)-1H-indole Derivatives Against Pancreatic Cancer Cells*

E. Giovannetti, G. Peters, D. Carbone, 2019, Anticancer Research.

Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cells.

E. Giovannetti, N. Funel, G. Peters, 2020, European journal of medicinal chemistry.

1,2,4-Oxadiazole topsentin analogs as staphylococcal biofilm inhibitors targeting the bacterial transpeptidase sortase A.

E. Giovannetti, D. Carbone, Simona Musella, 2020, European journal of medicinal chemistry.

Polymorphism at codon 213 within the p53 gene.

D. Carbone, T. Mitsudomi, I. Chiba, 1991, Oncogene.

Thiazoles, Their Benzofused Systems, and Thiazolidinone Derivatives: Versatile and Promising Tools to Combat Antibiotic Resistance

E. Giovannetti, D. Carbone, P. Diana, 2020, Journal of medicinal chemistry.

Therapeutic Strategies To Counteract Antibiotic Resistance in MRSA Biofilm‐Associated Infections

E. Giovannetti, D. Carbone, P. Diana, 2020, ChemMedChem.

Nobiletin and Xanthohumol Sensitize Colorectal Cancer Stem Cells to Standard Chemotherapy

M. Todaro, G. Stassi, D. Bellavia, 2021, Cancers.

A bug in the resistance to EGFR inhibitors: is there a role for Mycoplasma and cytidine deaminase in reducing the activity of osimertinib in lung cancer patients?

E. Giovannetti, G. Peters, Dong Deng, 2021, Journal of Cancer Research and Clinical Oncology.

Synthesis and Antioxidative Properties of 1,2,3,4-Tetrahydropyridine Derivatives with Different Substituents in 4-Position

D. Carbone, P. Diana, L. Tesoriere, 2022, Molecules.

SF3B1 modulators affect key genes in metastasis and drug influx: a new approach to fight pancreatic cancer chemoresistance

E. Giovannetti, A. Avan, G. Peters, 2021, Cancer drug resistance.

CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin

M. Todaro, G. Stassi, I. Screpanti, 2021, iScience.

Eight-membered heterocycles with two heteroatoms in a 1,2-relationship of interest in medicinal chemistry

D. Carbone, P. Diana, B. Parrino, 2021 .

Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer

E. Giovannetti, G. Peters, D. Carbone, 2018 .

“Open Sesame?”: Biomarker Status of the Human Equilibrative Nucleoside Transporter-1 and Molecular Mechanisms Influencing its Expression and Activity in the Uptake and Cytotoxicity of Gemcitabine in Pancreatic Cancer

E. Giovannetti, G. Peters, D. Carbone, 2020, Cancers.

Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa Bressac B, Kew M, Wands J, Ozturk M. Nature 1991;350:429?431

D. Carbone, 1991 .

Metabolomics-assisted discovery of a new anticancer GLS-1 inhibitor chemotype from a nortopsentin-inspired library: From phenotype screening to target identification.

A. Bertamino, P. Campiglia, D. Carbone, 2022, European journal of medicinal chemistry.

1,2,4-Amino-triazine derivatives as pyruvate dehydrogenase kinase inhibitors: Synthesis and pharmacological evaluation.

S. Moro, D. Carbone, V. Gandin, 2023, European journal of medicinal chemistry.

Thiazole Analogues of the Marine Alkaloid Nortopsentin as Inhibitors of Bacterial Biofilm Formation

D. Carbone, P. Diana, A. Carbone, 2020, Molecules.

Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal Adenocarcinoma

S. Moro, D. Carbone, V. Gandin, 2023, International journal of molecular sciences.

1,2,4‐Oxadiazole Topsentin Analogs with Antiproliferative Activity against Pancreatic Cancer Cells, Targeting GSK3β Kinase

E. Giovannetti, D. Carbone, Simona Musella, 2020, ChemMedChem.

Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma.

S. Moro, D. Carbone, V. Gandin, 2023, Marine drugs.

Biofilm formation as valuable target to fight severe chronic infections.

E. Giovannetti, D. Carbone, P. Diana, 2022, Current medicinal chemistry.

Novel strategies in the war against antibiotic resistance.

D. Carbone, P. Diana, B. Parrino, 2021, Future medicinal chemistry.

Eight-membered heterocycles with two heteroatoms in a 1,5-relationship of interest in medicinal chemistry

D. Carbone, P. Diana, B. Parrino, 2020 .

Eight-membered heterocycles with two heteroatoms in a 1,3-relationship of interest in medicinal chemistry

D. Carbone, P. Diana, B. Parrino, 2021 .

Dynamic‐shared Pharmacophore Approach as Tool to Design New Allosteric PRC2 Inhibitors, Targeting EED Binding Pocket

Ugo Perricone, Giada De Simone, Alessandro Padova, 2020, Molecular informatics.

GSK3β as a novel promising target to overcome chemoresistance in pancreatic cancer.

E. Giovannetti, G. Peters, Y. Assaraf, 2021, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

G. Sethi, B. Geoerger, D. Fruman, 2023, Molecular Cancer.

A Combination of Polymethoxyflavones from Citrus sinensis and Prenylflavonoids from Humulus lupulus Counteracts IL-1β-Induced Differentiated Caco-2 Cells Dysfunction via a Modulation of NF-κB/Nrf2 Activation

P. Campiglia, D. Carbone, E. Salviati, 2023, Antioxidants.

Recent Developments in the Inhibition of Bacterial Adhesion as Promising Anti-Virulence Strategy

D. Carbone, P. Diana, B. Parrino, 2023, International journal of molecular sciences.

Inhibitors of antibiotic resistance mechanisms: clinical applications and future perspectives.

D. Carbone, P. Diana, B. Parrino, 2020, Future medicinal chemistry.

HIV-1-induced nuclear invaginations mediated by VAP-A, ORP3, and Rab7 complex explain infection of activated T cells

D. Carbone, D. Corbeil, P. Diana, 2023, Nature communications.

Nortopsentins as Leads from Marine Organisms for Anticancer and Anti-Inflammatory Agent Development

D. Carbone, B. Parrino, P. Diana, 2023, Molecules.

marine drugs

E. Giovannetti, D. Carbone, P. Diana, 2022 .

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

G. Sethi, B. Geoerger, D. Fruman, 2023, Molecular Cancer.

Multi or Single-Kinase Inhibitors to Counteract Drug Resistance in Cancer: What's New?

D. Carbone, P. Diana, B. Parrino, 2022, Current medicinal chemistry.

5th I.A.S.L.C. Lung Tumor Biology Workshop, August 13-17, 1996, Ermatingen, Switzerland.

D. Carbone, M. Mabry, H. Poulsen, 1997, Lung cancer.

Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies

D. Carbone, G. Keum, Radwan Alnajjar, 2024, Pharmaceuticals.

Novel [1,3,4]Thiadiazole[3,2-a]pyrimidin-5-ones as Promising Biofilm Dispersal Agents against Relevant Gram-Positive and Gram-Negative Pathogens

D. Carbone, B. Parrino, P. Diana, 2024, Marine drugs.

Mechanisms of Sensitivity and Resistance to CDK4/CDK6 Inhibitors in Hormone Receptor-positive Breast Cancer Treatment

R. D. de Bruin, D. Carbone, S. Wander, 2024, Drug Resistance Updates.

marine drugs

S. Moro, D. Carbone, V. Gandin, 2022 .

Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic Target

E. Giovannetti, Y. Assaraf, D. Carbone, 2024, International journal of biological sciences.